戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 line, triglycerides, cholesteryl esters, and nonesterified fatty acids).
2 essing harmful intracellular accumulation of nonesterified fatty acid.
3 iators, lysophosphatidylcholine and oxidized nonesterified fatty acid.
4 orary storage site for energy in the form of nonesterified fatty acids.
5 ercise elicit an immediate increase in serum nonesterified fatty acids.
6 nge in the pattern of total, esterified, and nonesterified fatty acids.
7 rations, and were negatively associated with nonesterified fatty acids.
8 ators, lyso-phosphatidylcholine and oxidized nonesterified fatty acids.
9 is likely due to decreased beta-oxidation of nonesterified fatty acids.
10 was accounted for by MAP, triglycerides, and nonesterified fatty acids.
11 creases cholesterol synthesis and release of nonesterified fatty acids.
12 erol (12 +/- 3 to 258 +/- 47 micromol/l) and nonesterified fatty acid (194 +/- 10 to 540 +/- 80 micro
13 tion into triglyceride-rich lipoproteins and nonesterified fatty acid, AEE, and muscle markers were s
14 racteristic decrease from baseline in plasma nonesterified fatty acids after a mixed meal was inhibit
15              The d31-palmitate appearance in nonesterified fatty acid and very-low-density lipoprotei
16  had a lower concentration of fasting plasma nonesterified fatty acids and less hepatic steatosis.
17                                              Nonesterified fatty acids and lipid peroxidation were in
18 atty acyl chains from phospholipids to yield nonesterified fatty acids and lysophospholipids.
19 ease plasma concentrations of both TGRLs and nonesterified fatty acids and meal 2 to increase TGRLs o
20         In contrast, the liver pool sizes of nonesterified fatty acids and triglycerides were not alt
21 r epididymal fat pads, lower blood levels of nonesterified fatty acids and triglycerides, and higher
22                         Lipolysis (glycerol, nonesterified fatty acids) and endogenous glucose produc
23 ous glucose production, lipolysis (glycerol, nonesterified fatty acid), and glycogenolysis (lactate)
24 i on exercise capacity, oxygen uptake, serum nonesterified fatty acid, and glucose were measured duri
25 ty lipoproteins, cholesterol, triglycerides, nonesterified fatty acids, and leptin, whereas adiponect
26 ced physical activity; increased circulating nonesterified fatty acids; and increased IMCLs, diacylgl
27                                              Nonesterified fatty acids are key intermediates in cellu
28  plasma glucose, branched chain amino acids, nonesterified fatty acids, beta-hydroxybutyrate, and uri
29 ese results also suggest that esterified and nonesterified fatty acids can bind to and regulate prote
30                                        Blood nonesterified fatty acid concentration was not affected
31                                          The nonesterified fatty acid concentration was significantly
32 ion, it increased lipid oxidation and plasma nonesterified fatty acid concentrations compared with HF
33                                              Nonesterified fatty acid concentrations were lower up to
34 serum insulin, glucose, triacylglycerol, and nonesterified fatty acid concentrations were measured, a
35 ts in increased serum levels of glycerol and nonesterified fatty acids, consistent with increased lip
36 to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, i
37 zed de novo in the liver from carbohydrates, nonesterified fatty acids derived from adipose tissue, n
38 ied fatty acids derived from adipose tissue, nonesterified fatty acids derived from the spillover of
39 ucagon-like peptide 1, insulin, glucose, and nonesterified fatty acids determined for 4 h.
40                Metabolic profiling of plasma nonesterified fatty acids discovered that palmitic acid
41  mass spectrometry was used to analyze free (nonesterified) fatty acid (FFA) and triacylglycerol flux
42      Plasma concentrations of triglycerides, nonesterified fatty acids, glucose, and insulin were mon
43 ed at 10-min intervals; blood triglycerides, nonesterified fatty acids, glucose, lactate, inflammator
44                     Pathologically increased nonesterified fatty acids have widely been viewed as a k
45  beta-cell membrane phospholipids to release nonesterified fatty acids, including AA, and inhibiting
46 ome in db mice contributed high-glucose- and nonesterified fatty acid-induced osteoblast apoptosis th
47  the percentage of small dense LDL; glucose; nonesterified fatty acids; insulin; and the homeostasis
48                           Adipose release of nonesterified fatty acids into plasma decreased by 53% a
49 eficient mice cleared blood triglyceride and nonesterified fatty acid less efficiently than wild-type
50 n of glucagon secretion, reduction in plasma nonesterified fatty acid level, decrease in the load of
51 ratio (P = 0.013), and, surprisingly, higher nonesterified fatty acid levels (P = 0.01).
52 ion decreases serum triacylglycerol (TG) and nonesterified fatty acid levels and improves insulin sen
53 rization associated with reduced circulating nonesterified fatty acid levels and normal glucose homeo
54                     Fasting increased plasma nonesterified fatty acid levels in both lean and obese r
55 olysis but did not result in increased serum nonesterified fatty acid levels or ectopic TAG storage.
56 nd beta cell volume without affecting plasma nonesterified fatty acid levels, strongly suggesting tha
57 ks, without significant alteration of plasma nonesterified fatty acid levels.
58                                              Nonesterified fatty acids may influence mitochondrial fu
59 andial responses in plasma concentrations of nonesterified fatty acid (meal x time, P = 0.00014), tri
60 ution exerts a major influence on endogenous nonesterified fatty acid metabolism, which may in turn m
61 ctives were to determine the impact of KE on nonesterified fatty acid (NEFA) concentration and glucor
62 opic hormone (ACTH), cortisol, glucagon, and nonesterified fatty acid (NEFA) concentrations were not
63 ndrial function independent of reductions in nonesterified fatty acid (NEFA) concentrations.
64 VLDL particle and TG transport rates, plasma nonesterified fatty acid (NEFA) flux, and sources of fat
65 2)H(2)]palmitic acid to investigate systemic nonesterified fatty acid (NEFA) incorporation into VLDL
66 f various hormones and an increase in plasma nonesterified fatty acid (NEFA) levels and is mediated t
67 arin (0.5 U x kg(-1) x min(-1)) to clamp the nonesterified fatty acid (NEFA) levels during hyperinsul
68                          Elevation of plasma nonesterified fatty acid (NEFA) levels has been shown in
69 widely regarded as monitors of intracellular nonesterified fatty acid (NEFA) levels.
70                                              Nonesterified fatty acid (NEFA) release was suppressed a
71 rd quantitative methods for determination of nonesterified fatty acid (NEFA) species are still missin
72 Determinants of insulin sensitivity based on nonesterified fatty acid (NEFA) suppression after oral g
73 ied BAT oxidative metabolism and glucose and nonesterified fatty acid (NEFA) turnover in 6 healthy me
74 ive metabolism and perfusion and glucose and nonesterified fatty acid (NEFA) turnover were determined
75                                       Plasma nonesterified fatty acids (NEFA) at elevated concentrati
76                                     Although nonesterified fatty acids (NEFA) have been positively as
77                                              Nonesterified fatty acids (NEFA) in urine are bound to a
78 gy for simultaneous quantitative analysis of nonesterified fatty acids (NEFA) species in biofluids is
79 ipose tissue lipolysis produces glycerol and nonesterified fatty acids (NEFA) that serve as energy so
80 ntrol subjects, but the rates of delivery of nonesterified fatty acids (NEFA) were downregulated, res
81               To evaluate the association of nonesterified fatty acids (NEFA) with dysglycemia in old
82 in resistance despite increasing circulating nonesterified fatty acids (NEFA), the main substrate for
83  mechanism involves leakage of albumin-bound nonesterified fatty acids (NEFAs) across the damaged glo
84               Impaired suppression of plasma nonesterified fatty acids (NEFAs) after glucose ingestio
85                    We studied the effects of nonesterified fatty acids (NEFAs) and adipokines on acin
86 hus examined whether lipolytic generation of nonesterified fatty acids (NEFAs) from circulating trigl
87                    Experimental elevation of nonesterified fatty acids (NEFAs) impairs endothelial fu
88 HDL, and LDL cholesterol; triglycerides; and nonesterified fatty acids (NEFAs) in a total of 139 OT1D
89  tissue increases lipolysis and the entry of nonesterified fatty acids (NEFAs) in the liver, whereas
90 issue there was significant uptake of plasma nonesterified fatty acids (NEFAs) in the postprandial bu
91 t growth factor 21 (FGF21), adiponectin, and nonesterified fatty acids (NEFAs) may be involved in ami
92 in conscious dogs to determine the effect of nonesterified fatty acids (NEFAs) on net hepatic glucose
93          We compared FAEEs levels with their nonesterified fatty acids (NEFAs) precursors during alco
94         Preliminary data suggest that plasma nonesterified fatty acids (NEFAs) raise plasma ANGPTL4 c
95   Autonomic symptom scores, lipid oxidation, nonesterified fatty acids (NEFAs), and glycerol response
96 isotopes for 4 days to label and track serum nonesterified fatty acids (NEFAs), dietary fatty acids,
97                High plasma concentrations of nonesterified fatty acids (NEFAs), transported bound to
98 rgans to circulating triglycerides (TGs) and nonesterified fatty acids (NEFAs), ultimately leading to
99 ed adipose triglyceride and generated excess nonesterified fatty acids (NEFAs), which caused organ fa
100 ic than hGV but releases a lower quantity of nonesterified fatty acids (NEFAs).
101  (VLDL)-triacylglycerols and plasma free FA [nonesterified fatty acids (NEFAs)] were analyzed by usin
102                            Adipo-IR (fasting nonesterified fatty acids [NEFAs] x fasting insulin) was
103 r (P < 0.05), whereas glucose (P < 0.05) and nonesterified fatty acids (P < 0.0001) were higher.
104 occurred with elevated glucose, insulin, and nonesterified fatty acids peak after lunch.
105 fasting plasma insulin (r = 0.60, P < 0.05), nonesterified fatty acid (r = 0.63, P < 0.02), and gluco
106 y deplete [Ca(2+)](m) and thus contribute to nonesterified fatty acid-responsive mitochondrial dysfun
107 ction similarly in all groups and suppressed nonesterified fatty acids similarly between control subj
108  of glucose, lactate, and ketones and higher nonesterified fatty acids than wild type (WT) littermate
109 es results in the liberation of glycerol and nonesterified fatty acids that are released into the vas
110 n the dose-response curve for suppression of nonesterified fatty acids versus insulin levels in the N
111                                 This fall in nonesterified fatty acid was accompanied by a fall in th
112         Neither lipolysis nor flux of plasma nonesterified fatty acids were altered compared with bas
113 pid, triacylglycerol, cholesteryl ester, and nonesterified fatty acid) were extracted from fasting ba
114 fied non-HDL-cholesterol, triglycerides, and nonesterified fatty acids, with a minimum effective dose

 
Page Top